Fortis Gurgaon’s Cancer Centre treats over 5,500 patients annually, with immunotherapy as a core therapy. The centre holds NABH accreditation – India’s equivalent to Australian standards. Keytruda treatment may cost around A$4,500–A$10,800, covering the drug and clinical care. Advanced equipment includes the Da Vinci robot and CyberKnife for precise delivery. A dedicated coordinator supports international patients, with the hospital 20 km from Delhi airport.